Skip to content

Menu

Robinson & Cole LLP logo
About UsOur PracticeContactTopics
Search
Close
Subscribe

Health Law Diagnosis

Monitoring the Pulse of Health Care and Life Sciences

off-label prescribing

Subscribe to off-label prescribing via RSS

Rhode Island Issues Emergency Regulations on Off-Label Prescribing for COVID-19, and Guidance on Telehealth and Reciprocal Licensure

By Robinson+Cole's Health Law Group on March 24, 2020
Posted in COVID-19, FDA, Legislation, Medicare and Medicaid, Pharmaceuticals and Biologics, Physicians and Allied Health Professionals, Telehealth

Rhode Island has issued important updates for health care providers related to COVID-19, available at https://health.ri.gov/diseases/ncov2019/for/providers/.  Providers should be aware of these updates including, among others, the following described below.
Continue Reading Rhode Island Issues Emergency Regulations on Off-Label Prescribing for COVID-19, and Guidance on Telehealth and Reciprocal Licensure

Health Law Diagnosis

Our Authors
Robinson & Cole LLP logo
Connecticut•Massachusetts•New York•Washington DC•Rhode Island•Florida•California•Delaware•Pennsylvania•Texas
Join Us on Facebook View Our LinkedIn Profile RSS Follow Us on X
Privacy PolicyTerms of UseDisclaimerCalifornia Privacy Rights Notice
  • Home
  • About Us
  • Our Practice
  • Contact

The Robinson+Cole Health Law Group serves health care and life sciences clients regionally, nationally and globally. We are experienced lawyers trained to help clients meet their business objectives within complicated legal and regulatory environments. Our team understands the challenges of competition, regulation, and resource allocation. We focus on providing practical solutions and responsive counsel to our clients.

Read More...

Topics

Archives

Copyright © 2026, Robinson & Cole LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo

Please note that as of January 1, 2023 our Privacy Policy has changed. Click here for details on our new terms.

OK